Diabetes may accelerate blood cancer growth, yet survival outcomes differ by race

Patients with multiple myeloma (a blood cancer of plasma cells in the bone marrow) who also have diabetes have a reduced overall survival when compared to those without diabetes. But in a subgroup analysis, this difference in survival due to diabetes was seen in white patients but not in Black patients, according to a study published today in Blood Advances.

Leave A Comment

Your email address will not be published. Required fields are marked *